Projects per year
- Director, Health Economics Consulting, UEA
- FFPH Fellow Faculty of Public Health (by distinction)
- Expert member Public Health Interventions Advisory Committee (NICE)
Professional Qualifications and professional memberships
- BA (Hons) Economics/Economic History, University of York
- MA Health Services Studies, University of Leeds
- PhD Health Economics, University of Western Australia
- Fellow of the Faculty of Public Health (FFPH) by distinction
- Health Economists Study Group, UK
- economics of public health & social care
- priority setting methods in healthcare and public health
- economics of drug prevention and treatment
- return on investment in healthcare
- economics of bone health
- economics of alternative therapies
- economic evaluation of orthopaedics, joint replacement and falls, the subject of my doctoral thesis
Key Research Interests and Expertise
Ric’s research covers the development of priority setting techniques in complex decision making environments and he has adapted these for appropriate use in the practice of public health and World Class commissioning. His other work covers the use of economic evaluation techniques in wider public health and social issues such as obesity and food consumption, physical activity, drug and alcohol mis-use, parenting programmes, assistive technologies and other social care interventions. Throughout all these investigations he is interested in identifying, attributing and measuring the widest possible set of social and economic costs and benefits derived from these types of programme.
Ric has a longstanding interest too in the economics of orthopaedics and associated quality of life (the subject of his PhD). He is a Co-investigator and lead Health Economist on the MRC’s SCCOP project, an multi-centre economic evaluation of screening for osteoporosis in elderly women.
Selected PublicationsNisser, A, Fordham, RJ, Abubakar, I and Bachmann, M (2011) The provider cost of treating tuberculosis in Bauchi State, Nigeria. Journal of Public Health in Africa, 2 (2).
Phillips, CJ, Fordham, RJ, Marsh, K, Bertranou, E, Davies, S, Hale, J, Kingsley, M, Parke, S, Porteous, C, Rance, J and Warm, D (2011) Exploring the role of economics in prioritization in public health: what do stakeholders think? European Journal of Public Health, 21 (5). pp. 578-584.
Fordham, RJ, Lambert, RA and Large, S (2010) Do referrals by NHS Direct save the NHS money? A cost-minimalisation study of 1,001 NHS Direct users. BMJ.
Ball, H, Kemp, L and Fordham, RJ (2009) Road testing PBMA in three English regions: the Norfolk Mental Health PBMA Pilot. The Psychiatric Bulletin, 33 (1). pp. 141-144.
Fordham, RJ (2008) Towards Investment in Public Health: The Emergence of a Burden of Economic Proof. In: Future Public Health: Burdens, Challenges and Opportunities. Palgrave, Cambridge, England, pp. 265-275. ISBN 0230013597
Abubakar I, L Irvine, CF Aldus, GM Wyatt, RJ Fordham, S Schelenz, L Shepstone, A Howe, M Peck, PR Hunter. (2007) ‘A systematic review of the clinical, public health and cost-effectiveness of rapid diagnostic tests for the detection and identification of bacterial intestinal pathogens in faeces and food’. Health Technology Assessment Sep;11(36):1-216
Fordham RJ, Jones L, Sumnall HR, McVeigh J, Bellis MA. (2007) ‘The economics of preventing drug use: an introduction to the issues’ National Collaborating Centre for Drug Prevention of the National Institute of Health and Clinical Excellence ISBN 978-1-902051-505
Wilson E, Sussex J, Macleod & Fordham RJ. (2007) ‘Prioritizing health technologies in a Primary Care Trust’ J. Health Services Research and Policy Vol.12, No.2 April 2007
Wilson E, Fordham RJ. (2006) ‘Essential Thrombocythaemia: anagrelide or interferon-?? A cost-utility analysis’. Haematologica 91(s1):300
Heller R, Gemmel I, Wilson E, Fordham RJ, Smith RD. (2006) ‘Using economic analyses for local priority setting: the population cost-impact approach’. Journal of Applied Health Economics and Health Policy 5(1):45-54
Wilson E, Rees J & Fordham RJ. (2006) ‘Developing a prioritization framework in an English Primary Care Trust’ Cost Effectiveness and Resource Allocation (17.2.06), 4:3 & Open Access see: http:/www.resource-allocation.com/content/4/1/3
Miles S, Fordham RJ, Mills C, Valovirta E, Mugford M. (2005) ‘A framework for measuring the costs to society of IgE-mediated food allergy’ Allergy 60: 996-1003
Loxley W, Fordham RJ et al. (2004) ‘The prevention of substance use, risk and harm in Australia - a review of the evidence’. Ministerial Council on Drug Strategy monograph, Australian Government Department of Health and Ageing ISBN:0 642 82482 7
Senior Lecturer for Health Economics at Norwich Medical School. MBBS medical degree.
My goal is to span the understanding between academic and professional realms. I am an applied economist, research practitioner and teacher who uses economic methods in working alongside other
disciplines in the interests of building better health systems in the real world.
I have worked both in the NHS as a manager and consulted to various NHS bodies. I have also worked in the Australian and German health systems. As a former Associate Dean for Knowledge
Transfer I work with my clients in solving their actual problems and finding them the best possible solutions.
My early years were spent working at the Institute of Social and Economic Research,York for Alan Williams from whom I learned the art of 'working with what one has, not what one would necessarily
like' but in the most rigorous ways possible!
- I present papers regularly at international conferences and to the HESG, the professional Health Economists ‘body in the UK. My continuing professional development in public health is accredited annually by the Faculty of Public Health in order to retain my current membership status.
Dive into details
Select a country/territory to view shared publications and projects
A novel software application for the economic evaluation of new pharmaceutical and other health technologies
1/09/14 → 31/07/20
Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study) – a double-blind, parallel-arm randomised feasibility trialAtkins, C., Jones, A., Clark, A., Stockl, A., Fordham, R. & Wilson, A., 21 May 2021, In : BMJ Open Respiratory Research. 8, 1, e000814.
Research output: Contribution to journal › ArticleOpen AccessFile4 Downloads (Pure)
Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancerParsekar, K., Wilsher, S. H., Sweeting, A., Patel, A. & Fordham, R., 11 Jan 2021, In : BMJ Open. 11, e039412.
Research output: Contribution to journal › ArticleOpen AccessFile7 Downloads (Pure)
Xydopoulos, G., Fordham, R. & Fryer, A. A., 12 Feb 2020, In : BMJ Open Quality. 9, 1, 10 p., e000572.
Research output: Contribution to journal › ArticleOpen AccessFile13 Downloads (Pure)
Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trialO'Mahony, D., Gudmundsson, A., Soiza, R. L., Petrovic, M., Jose Cruz-Jentoft, A., Cherubini, A., Fordham, R., Byrne, S., Dahly, D., Gallagher, P., Lavan, A., Curtin, D., Dalton, K., Cullinan, S., Flanagan, E., Shiely, F., Samuelsson, O., Sverrisdottir, A., Subbarayan, S., Vandaele, L. & 14 others, , 1 Jul 2020, In : Age and Ageing. 49, 4, p. 605-614 10 p.
Research output: Contribution to journal › Article14 Citations (Scopus)
Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP studyCondurache, C. I., Chiu, S., Chotiyarnwong, P., Johansson, H., Shepstone, L., Lenaghan, E., Cooper, C., Clarke, S., Khioe, R. F. S., Fordham, R., Gittoes, N., Harvey, I., Harvey, N. C., Heawood, A., Holland, R., Howe, A., Kanis, J. A., Marshall, T., O'Neill, T. W., Peters, T. J. & 5 others, , Mar 2020, In : Osteoporosis International. 31, 3, p. 457–464 8 p.
Research output: Contribution to journal › ArticleOpen AccessFile1 Citation (Scopus)6 Downloads (Pure)